Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures
about
The role of trimetazidine in cardiovascular disease: beyond an anti-anginal agentClinical effect of trimetazidine on prevention of contrast-induced nephropathy in patients with renal insufficiency: An updated systematic review and meta-analysisTrimetazidine Decreases Risk of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease: A Meta-Analysis of Randomized Controlled Trials.Trimetazidine does not alter metabolic substrate oxidation in cardiac mitochondria of target patient population.Preventive effect of pretreatment with intravenous nicorandil on contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography (PRINCIPLE Study).The effect of L-carnitine on oxidative stress responses of experimental contrast-induced nephropathy in rats.Trimetazidine and cardioprotection: facts and perspectives.Contrast-induced acute kidney injury: A review of practical points.Preventing contrast nephropathy in catheter laboratory.Protective Role of Trimetazidine Against Neomycin-induced Hair Cell Damage in ZebrafishEffects of trimetazidine on the Akt/eNOS signaling pathway and oxidative stress in an in vivo rat model of renal ischemia-reperfusion.Effect of trimetazidine on preventing contrast-induced nephropathy in diabetic patients with renal insufficiency.Coenzyme Q10 combined with trimetazidine in the prevention of contrast-induced nephropathy in patients with coronary heart disease complicated with renal dysfunction undergoing elective cardiac catheterization: a randomized control study and in vivoPrevention of contrast-induced nephropathy through a knowledge of its pathogenesis and risk factorsEffectiveness of contrast-associated acute kidney injury prevention methods; a systematic review and network meta-analysis
P2860
Q26741061-0D063526-AFA1-407C-9D07-A282E854AA6CQ30235510-72453B4E-F0C9-4EDA-8CB7-BCD711B8898EQ35567713-422A246A-892B-479B-AB70-050655EF742EQ36797382-62DDBBF8-2D19-4236-B70A-270D5EDF112FQ36872875-C33C94B7-E20E-4069-A33E-DCE66DA93512Q37692670-6C3D8A5D-FC07-4552-B517-AA62C6C03064Q38203492-C7CFDB6E-0A59-4269-94B2-1EF1C2D1DB2BQ39327802-D841FB6C-E4E1-408D-86F6-BF9077060192Q42409825-19001073-135E-4CC7-A706-F3490C0035ECQ42793589-863F790D-AEE9-47A3-9183-CB9E1E330624Q46675779-2D0A2D69-72AA-4B69-8487-231096750E72Q49650869-DD5AC4A1-0D77-48A3-AAB4-B87ABA5528F9Q55370734-D6892D96-9EE5-478D-BC02-3DB1F180B626Q59100924-2A9D7E59-B402-4F52-9405-39EFF4DE5296Q59127199-70AC1128-5C29-4A8C-A21A-C6EBEB4AC032
P2860
Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures
@ast
Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures
@en
type
label
Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures
@ast
Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures
@en
prefLabel
Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures
@ast
Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures
@en
P2093
P2860
P356
P1433
P1476
Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures
@en
P2093
Alper O Onbasili
Aslihan Karul
Guzel Discigil
Harun Akar
Pinar Agaoglu
Tarkan Tekten
Yavuz Yeniceriglu
P2860
P304
P356
10.1136/HRT.2006.097477
P407
P577
2006-10-25T00:00:00Z